These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 23886797)
61. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582 [TBL] [Abstract][Full Text] [Related]
62. Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients. Driessen EJ; Aarts MJ; Bootsma GP; van Loon JG; Janssen-Heijnen ML Lung Cancer; 2017 Jun; 108():198-204. PubMed ID: 28625635 [TBL] [Abstract][Full Text] [Related]
63. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis. Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941 [TBL] [Abstract][Full Text] [Related]
64. Impact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer. Zhai X; Yang L; Chen S; Zheng Q; Wang Z Cancer Med; 2016 Sep; 5(9):2286-93. PubMed ID: 27367482 [TBL] [Abstract][Full Text] [Related]
65. Evaluation of the Simplified Comorbidity Score (Colinet) as a prognostic indicator for patients with lung cancer: a cancer registry study. Ball D; Thursfield V; Irving L; Mitchell P; Richardson G; Torn-Broers Y; Wright G; Giles G Lung Cancer; 2013 Nov; 82(2):358-61. PubMed ID: 24051083 [TBL] [Abstract][Full Text] [Related]
66. Immune Checkpoint Inhibitors in Real-World Treatment of Older Adults with Non-Small Cell Lung Cancer. Muchnik E; Loh KP; Strawderman M; Magnuson A; Mohile SG; Estrah V; Maggiore RJ J Am Geriatr Soc; 2019 May; 67(5):905-912. PubMed ID: 30698276 [TBL] [Abstract][Full Text] [Related]
67. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification]. Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272 [TBL] [Abstract][Full Text] [Related]
68. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer. Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696 [TBL] [Abstract][Full Text] [Related]
69. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence. Johnson AM; Hines RB; Johnson JA; Bayakly AR Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311 [TBL] [Abstract][Full Text] [Related]
70. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC. Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784 [TBL] [Abstract][Full Text] [Related]
71. Use of adjuvant chemotherapy for nonsmall cell lung cancer: Is advanced age a prognostic factor? Batum O; Anar C; Özdoğan Y; Ermin S; Yılmaz U Indian J Cancer; 2018; 55(3):282-287. PubMed ID: 30693895 [TBL] [Abstract][Full Text] [Related]
72. Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. Schwartz AG; Cote ML; Wenzlaff AS; Van Dyke A; Chen W; Ruckdeschel JC; Gadgeel S; Soubani AO J Thorac Oncol; 2009 Mar; 4(3):291-9. PubMed ID: 19190518 [TBL] [Abstract][Full Text] [Related]
73. Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities. Zhang D; Tailor TD; Kim C; Atkins MB; Braithwaite D; Akinyemiju T J Immunother; 2021 Jun; 44(5):198-203. PubMed ID: 33758148 [TBL] [Abstract][Full Text] [Related]
74. Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes. Dudani S; Zhu X; Yokom DW; Yamada A; Ho C; Pantarotto JR; Leighl NB; Zhang T; Wheatley-Price P Clin Lung Cancer; 2018 Jan; 19(1):e11-e18. PubMed ID: 28711384 [TBL] [Abstract][Full Text] [Related]
75. Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. David EA; Canter RJ; Chen Y; Cooke DT; Cress RD Ann Thorac Surg; 2016 Oct; 102(4):1101-9. PubMed ID: 27293147 [TBL] [Abstract][Full Text] [Related]
76. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer. Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154 [TBL] [Abstract][Full Text] [Related]
77. Radiotherapy for stage III non-small-cell lung carcinoma in the elderly (age ≥ 70 years). Aridgides PD; Janik A; Bogart JA; Duffy S; Rosenbaum P; Gajra A Clin Lung Cancer; 2013 Nov; 14(6):674-9. PubMed ID: 23891240 [TBL] [Abstract][Full Text] [Related]
78. Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer. Kehl KL; Lamont EB; McNeil BJ; Bozeman SR; Kelley MJ; Keating NL J Geriatr Oncol; 2015 May; 6(3):202-10. PubMed ID: 25662785 [TBL] [Abstract][Full Text] [Related]
79. Initial medical attention on patients with early-stage non-small cell lung cancer. Chen X; Gorlov IP; Ying J; Merriman KW; Kimmel M; Lu C; Reyes-Gibby CC; Gorlova OY PLoS One; 2012; 7(3):e32644. PubMed ID: 22412901 [TBL] [Abstract][Full Text] [Related]
80. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy. Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]